Status: current, Defined. Date: 30-Jun 2020. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4402091000168116 | Ferrovance C (ascorbic acid 500 mg + ferrous sulfate 325 mg) modified release tablet, 30 tablets (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4402101000168114 | Ferrovance C modified release tablet, 30 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ferrovance C modified release tablet, 30 | Is a | ferrous sulfate 325 mg (iron 105 mg) + ascorbic acid 500 mg modified release tablet, 30 | true | Inferred relationship | Some | ||
| Ferrovance C modified release tablet, 30 | Is a | trade product pack | true | Inferred relationship | Some | ||
| Ferrovance C modified release tablet, 30 | has TP | Ferrovance C | true | Inferred relationship | Some | ||
| Ferrovance C modified release tablet, 30 | has TPUU | Ferrovance C modified release tablet | true | Inferred relationship | Some | 162519213 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Ferrovance C modified release tablet, 30, bottle | Is a | True | Ferrovance C modified release tablet, 30 | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR